The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

SAN DIEGO, April 24, 2019 /PRNewswire/ -- Forge Therapeutics, Inc. (Forge) and Basilea Pharmaceutica International Ltd. (Basilea), a wholly-owned subsidiary of Basilea Pharmaceutica Ltd. [SIX: BSLN], ...

On Wednesday, JPMorgan analyst Michael Cho initiated coverage on Forge Global Holdings Inc (NYSE: FRGE) with a Neutral rating and a price target of $18.00. The stock, currently trading at $17.79, has ...

The average one-year price target for Forge Global Holdings (NYSE:FRGE) has been revised to $51.00 / share. This is an increase of 29.87% from the prior estimate of $39.27 dated November 7, 2025. The ...

The reiteration of the Market Outperform rating suggests that Citizens JMP believes Forge Global’s stock has the potential to perform better than the broader market. The $60.00 price target indicates ...

) has been revised to $45.90 / share. This is a decrease of 10.00% from the prior estimate of $51.00 dated December 18, 2025. The price target is an average of many targets provided by analysts. The ...

Analysts have updated their price target for Forge Global Holdings, reflecting a revised view of the stock, even though the detailed justification behind this shift has not been provided. With no ...